Panigrahi aurojyoti

• Senior Consultant Pulmonologist, SUM Ultimate Medicare, Bhubaneswar (2015–Present)
  • Specializing in chronic lung diseases such as COPD, asthma, and tuberculosis.
  • Conducting lung function tests, bronchoscopies, and critical respiratory care.
  • Leading awareness programs for respiratory health in rural Odisha.
• Associate Professor, MKCG Medical College, Berhampur (2010–2015)
  • Training medical students and residents in pulmonology.
  • Supervising clinical trials and research in respiratory medicine.
• Resident Doctor, AIIMS Delhi (2003–2010)
  • Specialized training in tuberculosis and respiratory critical care.
  • Managed ICU ventilator patients and lung disease cases.

• Lead investigator in a study on "Impact of Air Pollution on Respiratory Health in Eastern India" (Published in the Indian Journal of Pulmonology, 2019).
• Co-authored a research paper on "Tuberculosis Control Measures in India: Success and Challenges" (Presented at the National Respiratory Conference, 2021).
• Conducted a WHO-supported study on "Post-COVID Pulmonary Complications and Long-Term Effects".

• Best Pulmonologist Award – Indian Chest Society (2019).
• Excellence in Respiratory Medicine – Indian Medical Association (2020).
• National Healthcare Excellence Award – Ministry of Health, Government of India (2022).

Dr. Aurojyoti Panigrahi has made significant contributions to respiratory medicine and pulmonology, publishing research in renowned medical journals. His study, "Impact of Air Pollution on Respiratory Health in Eastern India", published in the Indian Journal of Pulmonology (2019), analyzed the link between environmental pollution and increasing lung disease cases. Additionally, he co-authored "Tuberculosis Control Measures in India: Success and Challenges", which was presented at the National Respiratory Conference (2021) and provided insights into the effectiveness of India's TB eradication programs. He also participated in a WHO-funded study on "Post-COVID Pulmonary Complications and Long-Term Effects", which focused on lung fibrosis and respiratory challenges faced by COVID-19 survivors. His research has contributed to advancing treatment methodologies and improving public awareness of respiratory health.